Brief title: FLOT65+
Design: A multicenter, randomised phase II trial on the therapy of advanced gastric cancer or adenocarcinoma of the esophagogastric junction in patients older than 65 years with specific regard of quality of life and pharmacogenetic risk profile
No of patients: 140
In the present phase II trial, the response rate, the pharmacogenetic risc profil, the quality of life and the safety and tolerability in patients with advanced gastric or esophagogastric cancer will be evauluated.
Prof. Dr. S.E. Al-Batran
Institut für Klinisch-Onkologische Forschung
Krankenhaus Nordwest GmbH
Steinbacher Hohl 2-26